Neuros Medical

Aliso Viejo, CA · Founded 2008 · Privately Held (backing)

Developer of neuromodulation technology designed to develop proprietary therapies for unmet needs in patients worldwide. Neuros Medical is based in Aliso Viejo, CA and was founded in 2008. It was valued at $164 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $224 million across 2 recorded rounds; the latest was a $56 million later-stage round in Jul 2025.

PMV mark · valuation
$164.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$224.1M
Last round
Later Stage VC
Jul 2025

Who backs Neuros Medical?

29 investors
InvestorType
United States Department of War—
Osage University PartnersVenture capital
Argonautic VenturesVenture capital
Jumpstart VenturesOther
JobsOhio VenturesVenture capital
iSelect FundVenture capital
EQT Life SciencesVenture capital
Rev1 VenturesVenture capital
Sea Purity InvestmentsFamily office
BF BelmontFamily office
+ 19 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Neuros Medical investors

29 investors are on record for Neuros Medical, including United States Department of War, Osage University Partners, Argonautic Ventures and Jumpstart Ventures. By type, the record holds 6 venture capital firms and 2 family offices. The later-stage round in Jul 2025 drew 28 investors.

Free account
More of Neuros Medical with a free account
  • ·The complete investor list: 29 names
  • ·Watch Neuros Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 29 firms already write checks for companies like Neuros Medical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View